Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(25 sites)
United States
Pa0019 114, Peoria, Arizona Pa0019 127, Apple Valley, California Pa0019 111, Covina, California Pa0019 117, Riverside, California Pa0019 125, San Leandro, California Pa0019 126, Temecula, California Pa0019 120, Whittier, California Pa0019 128, Whittier, California Pa0019 123, Fort Collins, Colorado Pa0019 113, South Miami, Florida Pa0019 134, Lansing, Michigan Pa0019 140, West Long Branch, New Jersey Pa0019 131, Albuquerque, New Mexico Pa0019 115, Duncansville, Pennsylvania Pa0019 116, Jackson, Tennessee Pa0019 136, Colleyville, Texas Pa0019 135, Mesquite, Texas Pa0019 121, Bellevue, Washington Pa0019 130, Beckley, West Virginia